162 related articles for article (PubMed ID: 32946006)
1. Podocyte sphingomyelin phosphodiesterase acid-like 3b decreases among children with idiopathic nephrotic syndrome.
Watanabe S; Hirono K; Aizawa T; Tsugawa K; Joh K; Imaizumi T; Tanaka H
Clin Exp Nephrol; 2021 Jan; 25(1):44-51. PubMed ID: 32946006
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of sphingomyelinase phosphodiesterase acid-like 3b in children with intractable nephrotic syndrome.
Watanabe S; Tsugawa K; Tsuruga K; Imaizumi T; Tanaka H
Pediatr Int; 2017 Oct; 59(10):1112-1115. PubMed ID: 29081073
[TBL] [Abstract][Full Text] [Related]
3. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.
Fornoni A; Sageshima J; Wei C; Merscher-Gomez S; Aguillon-Prada R; Jauregui AN; Li J; Mattiazzi A; Ciancio G; Chen L; Zilleruelo G; Abitbol C; Chandar J; Seeherunvong W; Ricordi C; Ikehata M; Rastaldi MP; Reiser J; Burke GW
Sci Transl Med; 2011 Jun; 3(85):85ra46. PubMed ID: 21632984
[TBL] [Abstract][Full Text] [Related]
4. The Importance of Sphingomyelin Phosphodiesterase Acid-Like 3b (SMPDL-3b) Levels in Kidney Biopsy Specimens of Children With Nephrotic Syndrome.
Kaya M; Girişgen İ; Yalçın N; Becerir T; Şenol H; Gülten G; Yüksel S
Fetal Pediatr Pathol; 2023 Dec; 42(6):936-949. PubMed ID: 37818552
[TBL] [Abstract][Full Text] [Related]
5. Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes.
Takahashi Y; Ikezumi Y; Saitoh A
Nephrology (Carlton); 2017 Jan; 22(1):49-57. PubMed ID: 26833819
[TBL] [Abstract][Full Text] [Related]
6. Rituximab treatment prevents the early development of proteinuria following pig-to-baboon xeno-kidney transplantation.
Tasaki M; Shimizu A; Hanekamp I; Torabi R; Villani V; Yamada K
J Am Soc Nephrol; 2014 Apr; 25(4):737-44. PubMed ID: 24459229
[TBL] [Abstract][Full Text] [Related]
7. Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Ravani P; Ponticelli A; Siciliano C; Fornoni A; Magnasco A; Sica F; Bodria M; Caridi G; Wei C; Belingheri M; Ghio L; Merscher-Gomez S; Edefonti A; Pasini A; Montini G; Murtas C; Wang X; Muruve D; Vaglio A; Martorana D; Pani A; Scolari F; Reiser J; Ghiggeri GM
Kidney Int; 2013 Nov; 84(5):1025-33. PubMed ID: 23739238
[TBL] [Abstract][Full Text] [Related]
8. Sphingomyelin Phosphodiesterase Acid-Like 3b is Essential for Toll-Like Receptor 3 Signaling in Human Podocytes.
Watanabe S; Hidenori U; Hashimoto S; Riko S; Aizawa T; Tsugawa K; Imaizumi T; Tanaka H
J Membr Biol; 2022 Feb; 255(1):117-122. PubMed ID: 34739556
[TBL] [Abstract][Full Text] [Related]
9. Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria.
Wasilewska A; Zoch-Zwierz W; Taranta-Janusz K; Kołodziejczyk Z
Scand J Urol Nephrol; 2011 Feb; 45(1):52-9. PubMed ID: 21034351
[TBL] [Abstract][Full Text] [Related]
10. Detection of urinary podocytes and nephrin as markers for children with glomerular diseases.
Wang P; Li M; Liu Q; Chen B; Ji Z
Exp Biol Med (Maywood); 2015 Feb; 240(2):169-74. PubMed ID: 25245074
[TBL] [Abstract][Full Text] [Related]
11. Daily urinary interleukin-11 excretion correlated with proteinuria in IgA nephropathy and lupus nephritis.
Chien JW; Chen WL; Tsui YG; Lee MC; Lin AY; Lin CY
Pediatr Nephrol; 2006 Apr; 21(4):490-6. PubMed ID: 16528544
[TBL] [Abstract][Full Text] [Related]
12. Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury.
Hara M; Yanagihara T; Kihara I; Higashi K; Fujimoto K; Kajita T
J Am Soc Nephrol; 2005 Feb; 16(2):408-16. PubMed ID: 15625073
[TBL] [Abstract][Full Text] [Related]
13. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-18 in urine and serum of children with idiopathic nephrotic syndrome.
Kiliś-Pstrusińska K; Medyńska A; Zwolińska D; Wawro A
Kidney Blood Press Res; 2008; 31(2):122-6. PubMed ID: 18391570
[TBL] [Abstract][Full Text] [Related]
15. Sphingomyelinase-like phosphodiesterase 3b mediates radiation-induced damage of renal podocytes.
Ahmad A; Mitrofanova A; Bielawski J; Yang Y; Marples B; Fornoni A; Zeidan YH
FASEB J; 2017 Feb; 31(2):771-780. PubMed ID: 27836988
[TBL] [Abstract][Full Text] [Related]
16. The glomerular permeability factors in idiopathic nephrotic syndrome.
Davin JC
Pediatr Nephrol; 2016 Feb; 31(2):207-15. PubMed ID: 25925039
[TBL] [Abstract][Full Text] [Related]
17. [Interleukin-17 concentration in serum and urine of children with idiopathic nephrotic syndrome].
Kiliś-Pstrusińska K; Zwolińska D; Medyńska A; Wawro A; Kordecki H
Przegl Lek; 2006; 63 Suppl 3():198-200. PubMed ID: 16898529
[TBL] [Abstract][Full Text] [Related]
18. Ectopic expression of CLDN2 in podocytes is associated with childhood onset nephrotic syndrome.
Kanno S; Kume Y; Maeda R; Ono A; Suyama K; Kawasaki Y; Hosoya M
Pediatr Res; 2019 Oct; 86(4):485-491. PubMed ID: 31086291
[TBL] [Abstract][Full Text] [Related]
19. Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol.
Ravani P; Bonanni A; Ghiggeri GM
BMJ Open; 2017 Mar; 7(3):e013319. PubMed ID: 28314744
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice.
Jamin A; Berthelot L; Couderc A; Chemouny JM; Boedec E; Dehoux L; Abbad L; Dossier C; Daugas E; Monteiro RC; Deschênes G
J Autoimmun; 2018 May; 89():149-161. PubMed ID: 29307588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
